Dialyl-Sulfide and Trans-Chalcone Prevent Breast Cancer by Targeting SULT1E1 and HIF1a-MMPs
August 23, 2024
Online ISSN: 1947-6027
About Genes & Cancer
Our mission is to combine research from the fields of genomics, bioinformatics, and modem genetics to determine how cancer cells overcome growth regulatory pathways.
We aim to cover all aspects of oncogenes, growth suppressor and apoptotic genes, and their roles in tumor development.
Inhibitory Effect of miR-377 on Prostate Cancer Cells
May 21, 2024
PRESS RELEASE: On May 16, 2024, a new research paper was published in Genes & Cancer, entitled, “Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4.” continue reading »
The Roles of USP1 in Ewing Sarcoma
February 14, 2024
PRESS RELEASE: A new research paper was published in Genes & Cancer on February 5, 2024, entitled, “Roles of USP1 in Ewing sarcoma.” continue reading »
Mechanistically Based Blood Proteomic Markers in the TGF-β Pathway Stratify Risk of HCC in Patients With Cirrhosis
February 9, 2024
PRESS RELEASE: On February 5, 2024, a new research paper was published in Genes & Cancer, entitled, “Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis.” continue reading »
Increased BRD4-L and BRD4-S Promotes Chemotherapy Resistance in Ovarian Carcinoma
September 13, 2023
PRESS RELEASE: On September 12, 2023, a new research paper was published in Genes & Cancer, entitled, “Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma.” continue reading »